Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Familial intrahepatic cholestasis: New and wide perspectives.

Vitale G, Gitto S, Vukotic R, Raimondi F, Andreone P.

Dig Liver Dis. 2019 May 16. pii: S1590-8658(19)30553-5. doi: 10.1016/j.dld.2019.04.013. [Epub ahead of print] Review.

PMID:
31105019
2.

Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study.

Gitto S, Vizzutti F, Schepis F, Turco L, Aspite S, Vitale G, Arena U, Villa E, Laffi G, Debernardi-Venon W, Fanelli F, Andreone P, Marra F; DAA-TIPS group.

Dig Liver Dis. 2019 Jun;51(6):870-874. doi: 10.1016/j.dld.2018.11.015. Epub 2019 Feb 7.

PMID:
30824409
3.

Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.

Gitto S, Marra F, De Maria N, Bihl F, Villa E, Andreone P, Burra P.

Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):173-178. doi: 10.1080/17474124.2019.1551132. Epub 2018 Nov 30.

PMID:
30791778
4.

Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B.

Loggi E, Vukotic R, Conti F, Grandini E, Gitto S, Cursaro C, Galli S, Furlini G, Re MC, Andreone P.

J Viral Hepat. 2019 May;26(5):568-575. doi: 10.1111/jvh.13054. Epub 2019 Jan 22.

PMID:
30576048
5.

Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.

Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, Buonfiglioli F, Vitale G, Ravaioli F, Gitto S, Verucchi G, Lenzi M, Bolondi L, Mazzella G, Brillanti S, Andreone P; member of the Bologna DAA group.

Dig Liver Dis. 2019 May;51(5):681-688. doi: 10.1016/j.dld.2018.09.016. Epub 2018 Sep 22.

PMID:
30327251
6.

Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods.

Conti F, Serra C, Vukotic R, Felicani C, Mazzotta E, Gitto S, Vitale G, D'Errico A, Andreone P.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):510-517.e3. doi: 10.1016/j.cgh.2018.06.027. Epub 2018 Jun 20.

PMID:
29935328
7.

Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study.

Cicero AFG, Gitto S, Fogacci F, Rosticci M, Giovannini M, D'Addato S, Andreone P, Borghi C; Brisighella Heart Study Group Medical and Surgical Sciences Dept., University of Bologna.

Eur J Intern Med. 2018 Jul;53:29-33. doi: 10.1016/j.ejim.2018.03.010. Epub 2018 Mar 24.

PMID:
29580767
8.

De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.

Gitto S, de Maria N, di Benedetto F, Tarantino G, Serra V, Maroni L, Cescon M, Pinna AD, Schepis F, Andreone P, Villa E.

Eur J Gastroenterol Hepatol. 2018 Jul;30(7):766-773. doi: 10.1097/MEG.0000000000001105.

PMID:
29505475
9.

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives.

Gitto S, Schepis F, Andreone P, Villa E.

Metabolites. 2018 Feb 24;8(1). pii: E17. doi: 10.3390/metabo8010017. Review.

10.

Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients.

Bianchini M, Cavani G, Bonaccorso A, Turco L, Vizzutti F, Sartini A, Gitto S, Merighi A, Banchelli F, Villa E, Schepis F.

Liver Int. 2018 Jul;38(7):1253-1262. doi: 10.1111/liv.13728. Epub 2018 Mar 25.

PMID:
29469184
11.

Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis.

Schepis F, Vizzutti F, Garcia-Tsao G, Marzocchi G, Rega L, De Maria N, Di Maira T, Gitto S, Caporali C, Colopi S, De Santis M, Arena U, Rampoldi A, Airoldi A, Cannavale A, Fanelli F, Mosconi C, Renzulli M, Agazzi R, Nani R, Quaretti P, Fiorina I, Moramarco L, Miraglia R, Luca A, Bruno R, Fagiuoli S, Golfieri R, Torricelli P, Di Benedetto F, Belli LS, Banchelli F, Laffi G, Marra F, Villa E.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1153-1162.e7. doi: 10.1016/j.cgh.2018.01.029. Epub 2018 Mar 3.

PMID:
29378312
12.

Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.

Sartini A, Gitto S, Bianchini M, Verga MC, Di Girolamo M, Bertani A, Del Buono M, Schepis F, Lei B, De Maria N, Villa E.

Cell Death Dis. 2018 Jan 24;9(2):87. doi: 10.1038/s41419-017-0124-2.

13.

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.

Gitto S, Cicero AFG, Loggi E, Giovannini M, Conti F, Grandini E, Guarneri V, Scuteri A, Vitale G, Cursaro C, Borghi C, Andreone P.

Ann Hepatol. 2018 January-February;17(1):64-75. doi: 10.5604/01.3001.0010.7536.

14.

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.

Gitto S, Cicero AFG, Loggi E, Giovannini M, Conti F, Grandini E, Guarneri V, Scuteri A, Vitale G, Cursaro C, Borghi C, Andreone P.

Ann Hepatol. 2018 Jan - Feb;17(1):64-75. doi: 10.5604/01.3001.0010.7536.

15.

Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.

Vitale G, Gitto S, Raimondi F, Mattiaccio A, Mantovani V, Vukotic R, D'Errico A, Seri M, Russell RB, Andreone P.

J Gastroenterol. 2018 Aug;53(8):945-958. doi: 10.1007/s00535-017-1423-1. Epub 2017 Dec 13.

PMID:
29238877
16.

The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.

Gitto S, Guarneri V, Sartini A, Andreone P.

Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):165-171. doi: 10.1080/17474124.2018.1399060. Epub 2017 Nov 3. Review.

PMID:
29082798
17.

Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients.

Simonetti G, Gitto S, Golfieri L, Gamal N, Loggi E, Taruschio G, Cursaro C, Nunzella S, Grandi S, Andreone P.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):14-20. doi: 10.1097/MEG.0000000000000999.

PMID:
29064847
18.

The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.

Carrai P, Morelli C, Cordone G, Romano A, Tamé M, Lionetti R, Pietrosi G, Lenci I, Piai G, Russo FP, Coppola C, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Martini S, Toniutto P; ITACOPS study group.

Transpl Int. 2017 Dec;30(12):1253-1265. doi: 10.1111/tri.13018. Epub 2017 Sep 7.

19.

Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.

Golfieri L, Gitto S, Morelli MC, Pinna AD, Grandi S, Andreone P.

Expert Rev Anti Infect Ther. 2017 Aug;15(8):759-765. doi: 10.1080/14787210.2017.1362334. Review.

PMID:
28756716
20.

Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?

Sartini A, Gitto S, Villa E.

Dig Dis Sci. 2017 Sep;62(9):2604-2606. doi: 10.1007/s10620-017-4665-0. Epub 2017 Jul 4. No abstract available.

PMID:
28676901

Supplemental Content

Loading ...
Support Center